Background Decitabine is an anticancer medicine that acts by epigenetic regulation of DNA. It activates viral elements in the human genome called endogenous retroviruses which, in turn, induce the expression of interferon-β that is designed […]
Introduction: Unraveling the Epigenetic Landscape of Breast Cancer “Breast cancer is the most commonly diagnosed malignancy in women. Despite advances in diagnostics and treatment, the key molecular mechanisms underlying its development remain incompletely understood.” This […]
Colorectal cancer remains a growing challenge Colorectal cancer (CRC) is the world’s third‑most frequently diagnosed malignancy, adding roughly 1.9 million new cases every year—about one in ten of all cancers. Even more concerning is the sharp […]
Understanding Lung Adenocarcinoma: A Silent Killer Lung cancer continues to be the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 80–85% of all cases, with lung adenocarcinoma (LUAD) being […]
Cervical Cancer Remains a Serious Global Health Challenge Cervical cancer is the second most common gynecologic cancer worldwide and remains a major cause of cancer-related death in women. In 2018 alone, an estimated 18.1 million […]
Understanding the Stakes: Lung Cancer and the PD-L1 Challenge Lung cancer is the most diagnosed cancer worldwide, with nearly two million new cases reported each year. Among its types, non-small cell lung cancer (NSCLC) dominates […]
A Fresh Approach to Treating Diffuse Large B-Cell Lymphoma (DLBCL) Diffuse large B-cell lymphoma (DLBCL) is the most common and aggressive type of non-Hodgkin lymphoma (NHL), a group of cancers that affect the lymphatic system. […]
Could CRELD2 Be a Key Biomarker in Triple-Negative Breast Cancer? A new study from researchers at Necmettin Erbakan University suggests that a specific protein, CRELD2, might help predict outcomes for patients with triple-negative breast cancer […]
Peer review is crucial in the scientific publishing process, as it ensures that research papers meet high-quality and accurate standards. Each month, the BiomolBiomed Editorial team recognizes a reviewer who has delivered outstanding and constructive […]
Lung cancer is the leading cause of cancer-related deaths globally, with nearly 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer cases. Most patients are diagnosed […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH